Smith Scott Thomas

Smith Scott Thomas is listed in filings as EVP & Chief Financial Officer at Ascendis Pharma A/S. This profile follows SEC Form 4 activity through Jun 2, 2026, including purchase activity. Recent filings connect the profile to Ascendis Pharma A/S (ASND). The current snapshot covers public activity from Jun 1, 2026 to Jun 2, 2026. Reported amounts are shown as $21.9K to $55.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.